ETHAMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ethamide, and when can generic versions of Ethamide launch?
Ethamide is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in ETHAMIDE is ethoxzolamide. Additional details are available on the ethoxzolamide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ETHAMIDE?
- What are the global sales for ETHAMIDE?
- What is Average Wholesale Price for ETHAMIDE?
Summary for ETHAMIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 65 |
| Patent Applications: | 1,288 |
| DailyMed Link: | ETHAMIDE at DailyMed |
US Patents and Regulatory Information for ETHAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | ETHAMIDE | ethoxzolamide | TABLET;ORAL | 016144-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
